Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
Bank of America and Ford recently flashed bullish signals after their golden crosses, but retirees must weigh income ...
Investors aiming to replace a $60,000 salary with monthly dividend ETFs face a simple math problem: how much capital ...
Target stock has captured attention as it tries to outpace rivals like Amazon, Walmart, and Costco. This guide breaks...
PepsiCo reported higher revenue, yet its stock hovered near a 52-week low as investors weighed costs, margins, and gr...
A new funding framework is here. The housing 21st century brings new loan options and smarter ways to build and prese...
A leading advisory group signals a shift toward gold over silver as volatility spikes, citing safety, liquidity, and ...
A disciplined value-focused approach has outpaced the S&P 500 for almost five years, signaling a leadership shift as ...
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
This year has brought a 28% pullback for Reddit, raising questions about its growth and future. But stocks don’t move...